Jeff Ross

ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features

M. Zoche, Hisham Fansa, Bernhard C Pestalozzi, 2024, The journal of pathology. Clinical research.

Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.

D. Lin, G. Bratslavsky, P. Grivas, 2024, Targeted oncology.

Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes

D. Jin, N. Danziger, K. McGregor, 2024, Breast cancer research : BCR.